Clinical Trial Update: A Randomized Trial to Assess the Efficacy and Safety of GO2KA1(Chitosan Oligosaccharide)on Blood Glucose Control [Phase 2, Phase 3]

View source ↗

Summary

Completed randomized Phase 2/3 trial evaluating GO2KA1 (chitosan oligosaccharide) for blood glucose control in adults with impaired fasting glucose and newly di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose
• Type 2 Diabetes Mellitus

Drugs mentioned

• GO2KA1 (Chitosan oligosaccharide)

Snippet

Sponsor: Yonsei University | Conditions: Impaired Fasting Glucose, Newly-diagnosed Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED